As more lung cancer cases emerge among non-smokers, advances in medical imaging technology are helping doctors detect the disease earlier while reducing radiation exposure.
Low-dose computed tomography (CT) screening can cut the risk of dying from lung cancer by 16% in high-risk people, while also ...
Low-dose CT (LDCT) is the only lung cancer screening modality proven in randomized trials to reduce lung cancer mortality, by approximately 20% in eligible high-risk adults. It uses substantially ...
Health and Me on MSN
IARC says low-dose CT can cut lung cancer deaths: AIIMS expert explains why India needs its own screening evidence
In the US, LDCT was linked to a 16% lower risk of lung cancer death at 7 years, while a European trial found lower mortality ...
Low-dose computed tomography (LDCT) is an effective screening tool for early lung cancer detection; however, it frequently reveals incidental findings (IFs) beyond suspicious pulmonary nodules. We ...
Lung cancer screening eligibility increased markedly from 2018–2023 under USPSTF criteria, reflecting aging and substantial ...
Results from the Female Asian Nonsmoker Screening Study (FANSS) highlight the potential value of low-dose CT (LDCT) screening for lung cancer among a growing but underserved population: Asian women ...
For adults with a history of smoking undergoing low-dose computed tomography (LDCT) for lung cancer screening, emphysema is predictive of mortality up to 25 years, according to a study published ...
Forbes contributors publish independent expert analyses and insights. Dr. Omer Awan is a practicing physician who covers public health. Lung cancer screening remains strikingly underused, with ...
Please provide your email address to receive an email when new articles are posted on . Awareness of the fact that lung cancer screening is available for adults at high risk was reported by 33% of ...
Lung cancer screening programs built around low-dose computed tomography are catching tumors earlier than ever before, and ...
Winship Cancer Institute of Emory University is advancing its commitment to reducing lung cancer deaths across Georgia with the launch of the Emory Healthcare Lung Screening and Nodule Program on Dec.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results